Abstract
After a wide review of the role of palliative chemotherapy in non-resectable malignant pleural mesothelioma, this chapter illustrates promising future research directions. The role of thymidylate synthase and of excision repair crosscomplementation group 1 expression has been found to significantly correlate with prognosis. Several approaches to improve the efficacy of platinum salts are being explored. The search for novel antifolates (i.e. pralaxate and GW1843) as well as thymidilate synthase (i.e. plevitrexed and BGC 945) is ongoing. The platinum-based regimens could benefit from the addition of bevacizumab and amatuximab, monoclonal antibody against the vascular endothelial growth factor and mesothelin, respectively.
Keywords: Chemotherapy, maintenance therapy, pemetrexed, raltitrexed.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Alzheimer Research
Current Aging Science
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents